Several partners in the Cell & Gene Therapy and Connected Health Initiative participated in the recent HLTH Conference, held October 27-30, in Las Vegas. The event attracted 6,000 senior leaders from across the healthcare ecosystem, including payers and providers, employers, investors, startups, pharma, government, and health associations and organizations.
Among the 2019 presenters and moderators from our region were Madeline Bell, President and CEO, Children’s Hospital of Philadelphia; Carina Edwards, CEO, Quil Health; Dr. Ezekiel Emanuel, Chair, Department of Medical Ethics and Health Policy, University of Pennsylvania; and Dr. Janice Nevin, President and CEO, ChristianaCare. The speakers were featured as part of conference tracks and session topics that included Precision Medicine, Bold New Entrants, A Commitment to Wellness, and Fringes of Health Science.
More opportunities to share news of the Greater Philadelphia region’s leadership role in cell and gene therapy, gene editing, and connected health emerge in 2020. Among the upcoming first quarter meetings that will be attended by partners in the initiative are the J.P. Morgan Healthcare Conference in San Francisco from January 13-18; Immuno-Oncology 360° in New York from February 26-28; HIMSS20 Global Health Conference & Exhibition in Orlando, Florida, from March 9-13; and the South by Southwest (SXSW) Conference’s Health & Medtech track in Austin, Texas, from March 13-17.
The Cell & Gene Therapy and Connected Health toolkit offers messaging, presentation templates, photos and videos for exhibitors and speakers to use at conferences and meetings. Take a look and see what might be useful for you.
Finally, mark your calendar for the HLTH Conference in 2020, which returns to Las Vegas October 11-14.